Literature DB >> 25441172

Admission blood glucose predicted haemorrhagic shock in multiple trauma patients.

Janett Kreutziger1, Andreas Rafetseder2, Simon Mathis3, Volker Wenzel4, René El Attal5, Stefan Schmid6.   

Abstract

INTRODUCTION: Admission blood glucose is known to be a predictor for outcome in several disease patterns, especially in critically ill trauma patients. The underlying mechanisms for the association of hyperglycaemia and poor outcome are still not proven. It was hypothesised that hyperglycaemia upon hospital admission is associated with haemorrhagic shock and in-hospital mortality.
METHODS: Data was extracted from an observational trauma database of the level 1 trauma centre at Innsbruck Medical University hospital. Trauma patients (≥18 years) with multiple injuries and an Injury Severity Score ≥17 were included and analysed.
RESULTS: In total, 279 patients were analysed, of which 42 patients (15.1%) died. With increasing blood glucose upon hospital admission, the rate of patients with haemorrhagic shock rose significantly [from 4.4% (glucose 4.1-5.5mmol/L) to 87.5% (glucose >15mmol/L), p<0.0001]. Mortality was also associated with initial blood glucose [≤5.50mmol/L 8.3%; 5.51-7.50mmol/L 10.9%, 7.51-10mmol/L 12.4%; 10.01-15mmol/L 32.0%; ≥15.01mmol/L 12.5%, p=0.008]. Admission blood glucose was a better indicator for haemorrhagic shock (cut-off 9.4mmol/L, sensitivity 67.1%, specificity 83.9%) than haemoglobin, base excess, bicarbonate, pH, lactate, or vital parameters. Regarding haemorrhagic shock, admission blood glucose is more valuable during initial patient assessment than the second best predictive parameter, which was admission haemoglobin (cut-off value 6.5mmol/L (10.4g/dL): sensitivity 61.3%, specificity 83.9%).
CONCLUSIONS: In multiple trauma, non-diabetic patients, admission blood glucose predicted the incidence of haemorrhagic shock. Admission blood glucose is an inexpensive, rapidly and easily available laboratory value that might help to identify patients at risk for haemorrhagic shock during initial evaluation upon hospital admission.
Copyright © 2014 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Admission blood glucose; Haemorrhagic shock; Multiple trauma; Outcome

Mesh:

Substances:

Year:  2014        PMID: 25441172     DOI: 10.1016/j.injury.2014.09.018

Source DB:  PubMed          Journal:  Injury        ISSN: 0020-1383            Impact factor:   2.586


  5 in total

1.  A systematic scoping review on the consequences of stress-related hyperglycaemia.

Authors:  Elena Olariu; Nicholas Pooley; Aurélie Danel; Montserrat Miret; Jean-Charles Preiser
Journal:  PLoS One       Date:  2018-04-06       Impact factor: 3.240

2.  Trauma severity associated with stress index in emergency settings: an observational prediction-and-validation study.

Authors:  Hayato Taniguchi; Tomoki Doi; Takeru Abe; Ichiro Takeuchi
Journal:  Acute Med Surg       Date:  2020-03-04

3.  Assessing Hemorrhagic Shock Severity Using the Second Heart Sound Determined from Phonocardiogram: A Novel Approach.

Authors:  Yan Chen; Aisheng Hou; Xiaodong Wu; Ting Cong; Zhikang Zhou; Youyou Jiao; Yungen Luo; Yuheng Wang; Weidong Mi; Jiangbei Cao
Journal:  Micromachines (Basel)       Date:  2022-06-28       Impact factor: 3.523

4.  Association between Blood Glucose and cardiac Rhythms during pre-hospital care of Trauma Patients - a retrospective Analysis.

Authors:  Janett Kreutziger; Stefan Schmid; Nikolaus Umlauf; Hanno Ulmer; Maarten W Nijsten; Daniel Werner; Thomas Schlechtriemen; Wolfgang Lederer
Journal:  Scand J Trauma Resusc Emerg Med       Date:  2018-07-13       Impact factor: 2.953

5.  Patterns and Effects of Admission Hyperglycemia and Inflammatory Response in Trauma Patients: A Prospective Clinical Study.

Authors:  Ayman El-Menyar; Mohammad Asim; Fayaz Mir; Suhail Hakim; Ahad Kanbar; Tariq Siddiqui; Basil Younis; Khalid Ahmed; Ismail Mahmood; Sajid Atique; Hisham Al Jogol; Ibrahim Taha; Fuad Mustafa; Mohammad Alabdallat; Husham Abdelrahman; Ruben Peralta; Hassan Al-Thani
Journal:  World J Surg       Date:  2021-06-11       Impact factor: 3.352

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.